crabsallover highlights, key points, comments / links.
"Aspirin reduced death from gastrointestinal cancers and non-gastrointestinal solid cancers like those of the lung, prostate, bladder and kidney, but not from hematological cancers. This may be because aspirin seemed to only reduce deaths from cancers that are predominantly adenocarcinomas, meaning that they originated from epithelial cells — cells that line the cavities and organs in the body and thus form the boundary between one tissue and another. Aspirin had no effect on other, non-cancer deaths."
...
" In the future they plan to extend their analysis to beyond twenty years to look for any late rebound in cancer deaths, and to see if they can replicate their findings with alternate-day — instead of daily — aspirin."
"Aspirin reduced death from gastrointestinal cancers and non-gastrointestinal solid cancers like those of the lung, prostate, bladder and kidney, but not from hematological cancers. This may be because aspirin seemed to only reduce deaths from cancers that are predominantly adenocarcinomas, meaning that they originated from epithelial cells — cells that line the cavities and organs in the body and thus form the boundary between one tissue and another. Aspirin had no effect on other, non-cancer deaths."
...
" In the future they plan to extend their analysis to beyond twenty years to look for any late rebound in cancer deaths, and to see if they can replicate their findings with alternate-day — instead of daily — aspirin."
No comments:
Post a Comment